VRTX Vertex Pharmaceuticals, Inc.
Biotechnology NasdaqGS
Trading Signals (VRTX)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $453.53
- Medium Support $462.2
- Weak Support $470.86
Resistance Levels
- Weak Resistance $488.2
- Medium Resistance $496.86
- Strong Resistance $505.53
Stop Loss Suggestions
- Conservative $445.75
- Moderate $466.53
- Aggressive $457.86
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Short & Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (VRTX)
Quarterly Outlook :
2025-07-14
Bullish Scenario
from current 10.34%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
2025-07-14
Base Scenario
from current -2.07%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
2025-07-14
Bearish Scenario
from current -12.92%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
Annual Outlook
2025-07-14
Bullish Scenario
from current 20.67%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
2025-07-14
Base Scenario
from current -4.13%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
2025-07-14
Bearish Scenario
from current -25.84%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (16.17) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (55.27) is in bullish territory, indicating upward momentum. MACD line (-2.07) is below Signal line (-1.88) (bearish crossover), confirming downward momentum. Both lines are below zero, reinforcing bearish trend. Current Weekly ATR is 24.78, indicating the average weekly price range.
Technical Analysis (VRTX)
Trend Identification
EMA
Exponential Moving Average
Current price (479.53) is above both Short MA (453.64) and Long MA (458.48). This indicates strong bullish momentum. Short MA (453.64) is below Long MA (458.48), a bearish crossover ('Death Cross' if it's a significant period). This indicates a downward trend. MAs (453.64, 458.48, 470.57) show mixed alignment, suggesting market indecision or range-bound activity.
MACD
Moving Average Convergence Divergence
MACD line is above the Signal line (bullish crossover). This indicates upward momentum. Histogram (3.9400) is positive and expanding, confirming bullish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). This is a strong buy signal. Consider long positions.
ADX
Average Directional Index
ADX (19.94) indicates a weak or non-existent trend (ranging market). +DI (31.51) is above -DI (12.23), suggesting a bullish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI (2025-07-14)
Relative Strength Index
RSI (68.62) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2025-07-14)
On-Balance Volume
OBV (13444744.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-14)
Stochastic Oscillator
Stochastics (%K: 88.90, %D: 90.31) are in the overbought zone (above 80). This suggests the asset may be losing upward momentum. No clear bullish or bearish crossover signal currently. The lines are close or moving sideways. This is a strong sell signal, indicating potential downside.
CCI (2025-07-14)
Commodity Channel Index
CCI (177.24) is above +100. This suggests a strong upward momentum and an overbought condition. Consider profit-taking or looking for short entries cautiously. Confirm with price action; if price is making higher highs, momentum is strong. Look for pullbacks to enter long.
Volatility Measurement
ATR (2025-07-14)
Average True Range
Current ATR is 9.6300. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-14)
Volatility Bands
Current price (479.53) is above the Upper Bollinger Band (475.72). This often indicates an overextended move and a potential reversal downwards, or strong upward momentum ('walking the band'). Consider shorting or taking profit on long positions, but confirm with other indicators.
Risk Management & Potential Reversals (VRTX)
SAR (2025-07-14)
Parabolic Stop and Reverse
SAR points below price indicate bullish trend. Current SAR at 445.75 is 7.04% from price. Consider SAR as a potential stop-loss level to protect gains in an uptrend.
Stochastic (2025-07-14)
Overbought
Stochastic is in overbought territory (88.9). Monitor for potential bearish crossover or movement below 80, which could signal a reversal.
RSI (2025-07-14)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-14)
Reversal Perspective
Bands show normal bandwidth. Price is above the upper band, indicating overbought conditions or strong upward momentum. Expect a potential pullback or trend exhaustion.No indication of imminent volatility expansion or reversal.
Holder List Top 20 (VRTX)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Capital World Investors | INSTITUTIONAL | 28533308 | 11.1% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 23491161 | 9.14% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 21782933 | 8.47% | 2025-03-31 |
| Capital Research Global Investors | INSTITUTIONAL | 14536344 | 5.65% | 2025-03-31 |
| State Street Corporation | INSTITUTIONAL | 11788657 | 4.59% | 2025-03-31 |
| GROWTH FUND OF AMERICA | MUTUALFUND | 11339049 | 4.41% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 8111511 | 3.16% | 2025-03-31 |
| JPMORGAN CHASE & CO | INSTITUTIONAL | 7755645 | 3.02% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 7727184 | 3.01% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | MUTUALFUND | 7134492 | 2.78% | 2025-03-31 |
| Geode Capital Management, LLC | INSTITUTIONAL | 5761760 | 2.24% | 2025-03-31 |
| Wellington Management Group, LLP | INSTITUTIONAL | 5454748 | 2.12% | 2025-03-31 |
| Invesco QQQ Trust, Series 1 | MUTUALFUND | 5235182 | 2.04% | 2025-04-30 |
| Jennison Associates LLC | INSTITUTIONAL | 5062442 | 1.97% | 2025-03-31 |
| AMERICAN BALANCED FUND | MUTUALFUND | 4925687 | 1.92% | 2025-03-31 |
| NEW PERSPECTIVE FUND | MUTUALFUND | 4024523 | 1.57% | 2025-03-31 |
| INVESTMENT CO OF AMERICA | MUTUALFUND | 3904210 | 1.52% | 2025-03-31 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | MUTUALFUND | 3232355 | 1.26% | 2025-01-31 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | MUTUALFUND | 3225677 | 1.25% | 2025-04-30 |
| CAPITAL WORLD GROWTH & INCOME FUND | MUTUALFUND | 3108229 | 1.21% | 2025-03-31 |